- Characteristics of BRCA2 Mutated Prostate Cancer at Presentation.
- Han H, Park CK, Cho NH, Lee J, Jang WS, Ham WS, Choi YD, Cho KS.
- Int J Mol Sci. 2022 Nov 3;23(21):13426. doi: 10.3390/ijms232113426.
- PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer: Whom to Treat?
- Loguidice CT.
- OncLive. 2022 Oct 28.
- Review
- Free Full Text